Lead Trends, Seize Opportunities

Nov 21

雲象科技 1億5千萬 A+輪募資到位

21 Nov. 2022 台灣實績拓展歐日，以 AI 輔助樹立精準醫療新標準數位病理及醫療影像 AI 領導廠商 – 雲象科技宣布，今年十月底完成 A+ 輪募資，分別由日本 Ono Digital health Investment,...

Sep 27

國內首項「大腸鏡即時AI瘜肉偵測」智慧醫材認證

27 Sept. 2022 臺大醫院、國泰綜合醫院與雲象科技宣布，三方合作的「大腸鏡即時AI瘜肉偵測 aetherAI Endo」獲得衛福部TFDA醫材許可，加入打擊國人癌症之首—大腸癌的防治工作。這項成果，不僅可望利用AI輔助，提升大腸鏡檢查的效能，並且推動提升大腸癌篩檢...

Aug 29

Annual Meeting of JSDP

26-28 Aug., Tokyo The 20th JSDP, Japanese Society of Digital Pathology Annual Meeting focused on Digital Pathology and AI research. It is...

Aug 12

2022 Taipei Biotech Award

12 Aug. aetherAI Hema Bone Marrow Smear Differential Count has won 2022 Taipei Biotech Award – Interdisciplinary Excellence Gold Medal....

Jul 27

AI-assisted lymph node assessment workflow for detection improvement to shorten 30% review time

aetherAI—Asia’s leading medical image AI solution provider—has designed an AI-assisted lymph node assessment workflow, validated with...

May 26

Crucial Challenges in Digital Health Transformation

25 May 2022 aetherAI CEO Joe Yeh addressed this issue at a Digital Health Development Forum, initiated by PwC Taiwan and Taiwan Digital...

Mar 29

Insights Sharing at StartUp Taipei Gathering

29 March 2022 It’s an honor that aetherAI co-founder & CEO Joe Yeh was invited to give a remark about Smart Healthcare at a startup...

Feb 10

CGMH Linkou wins 2021 National Healthcare Quality Award for Smart Care

9 Feb 2022 恭喜林口長庚醫院！勇奪2021年第22屆「國家醫療品質獎」金獎，在競爭激烈的「智慧醫療類」90多個參賽隊伍中，脫穎而出。林口長庚醫院領先全國，以病理玻片全面數位化，5個AI模組陸續上線，榮獲台灣醫界最高殊榮。...

Jan 25

2022 kickoff with ME healthcare exhibitions

25 Jan. 2022 On Jan. 24 - 27, aetherAI's partners showcase its AI solutions at two major healthcare exhibitions in Dubai. At Medlab...

Dec 17, 2021

National Innovation Award 2021

17 Dec. 2021 Led by Dr. Chi-Long, Department of Pathology, Taipei Medical University Hospital (TMUH), our joint study, pathological...

Dec 1, 2021

aetherAI showcases AI-powered detection and AI diagnostic support for precision medicine

1st Dec. 2021 AI輔助篩檢大腸癌、肺癌及早追擊亞洲醫療影像AI領導廠商雲象科技aetherAI，透過在台灣數位病理人工智慧系統市佔第一的優勢，將AI應用導入包含大腸癌、血液疾病、肺癌、乳癌等診治，協助醫師進行癌症篩檢、輔助診斷。繼今年十月全球首例「骨髓抹片...

Nov 24, 2021

aetherAI obtains CE mark for AI-powered Hematology Diagnostic Support Application

24 Nov. 2021 aetherAI, Asia’s leading medical image AI solution provider, today announced CE Mark for aetherAI Hema, for automatic...

Oct 28, 2021

aetherAI’s Machine Learning Approach for T-cell Lymphomas Diagnosis Support published in Cancers

Published by Cancers, Oct. 2021 aetherAI presented a machine learning approach for accurate quantification of nuclear morphometrics and...

Oct 25, 2021

Taiwan’s Major Challenges in Precision Health

21 Oct. 2021 Precision Health has been highly promoted in Taiwan, marked as one of Six Core Strategic Industries by President Tsai in her...

Oct 13, 2021

The Annual Radiology Meeting (ARM) in UAE

10-12 Oct. 2021, Dubai aetherAI medical imaging AI solutions are showcased at the Annual Radiology Meeting (ARM) in UAE by partner MHC,...

Sep 23, 2021

Learn from Stockholm, digital startups in Taiwan strive for global markets.

16 Sept 2021 借鏡瑞典「獨角獸工廠」　台灣數位新創搶國際生意 TVBS News Report Synopsis The 2021 edition of the European innovation scoreboard shows that Sweden...

Sep 17, 2021

aetherAI and Novartis Taiwan team up to improve blood disease diagnosis using AI

16 Sept. 2021 aetherAI, Asia’s leading medical image AI solution provider, Novartis Taiwan, a leader in the pharmaceutical industry, and...

Sep 7, 2021

TDDW2021, Taiwan Digestive Disease Week

9/24-9/26/2021, Virtual aetherAI is honored to host a Satellite Symposium, sharing our experiences and commitment to bring the AI-Powered...

Aug 26, 2021

11 Top Taiwan Health Diagnostics Companies and Startups of 2021

June 26, 2021 by BestStartup.asia This article showcases our top picks for the best Taiwan-based Health Diagnostics companies. These...

Aug 26, 2021

AI is revolutionizing healthcare services; Taiwan-based providers make a breakthrough.

August 5, 2021, by Mirror Media Translated in brief As many global companies enter precision medicine; some face setbacks in commercial...